ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,585Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 1000

$623K Total Retail Price of All Prescriptions

Rank: 182 out of 1000

483 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 11,309 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 901 580 1 2
SIMVASTATIN 796 635 2 3
METFORMIN HCL 517 368 3 8
FUROSEMIDE 496 352 4 7
TRAMADOL HCL 457 345 5 13
LISINOPRIL 409 272 6 5
LEVOTHYROXINE SODIUM 390 310 7 4
MELOXICAM 373 279 8 14
CITALOPRAM HBR 356 251 9 17
GABAPENTIN 317 199 10 11
HYDROCHLOROTHIAZIDE 296 233 11 9
AMLODIPINE BESYLATE 278 223 12 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 264 171 13 20
POTASSIUM CHLORIDE 254 180 14 10
WARFARIN SODIUM 247 222 15 22
ATENOLOL 221 174 16 24
HYDROCODONE-ACETAMINOPHEN 176 95 S3 17 1
GLIMEPIRIDE 172 113 18 34
ALLOPURINOL 166 108 19 31
ZOLPIDEM TARTRATE 162 123 20 16
SPIRIVA 156 111 21 64
METHOCARBAMOL 154 77 R 22 79
ATORVASTATIN CALCIUM 153 110 23 18
BACLOFEN 152 64 24 129
NEXIUM 142 94 25 23
SERTRALINE HCL 141 86 26 26
AMITRIPTYLINE HCL 138 66 R 27 45
METOPROLOL TARTRATE 137 94 28 19
LOVASTATIN 136 96 29 41
RANITIDINE HCL 134 61 30 37
CIPROFLOXACIN HCL 132 93 31 46
LOSARTAN POTASSIUM 125 105 32 25
CARVEDILOL 125 110 32 15
PRAVASTATIN SODIUM 121 85 34 12
BUSPIRONE HCL 118 48 35 110
PROAIR HFA 115 53 36 50
CLONIDINE HCL 111 79 37 27
GEMFIBROZIL 107 75 38 105
TRAZODONE HCL 107 57 38 29
POLYETHYLENE GLYCOL 3350 105 77 40 69
FLUTICASONE PROPIONATE 102 52 41 40
DOXAZOSIN MESYLATE 97 90 42 111
CLOPIDOGREL 97 85 42 35
ATENOLOL-CHLORTHALIDONE 96 57 44 206
METOPROLOL SUCCINATE 95 71 45 21
DIGOXIN 95 63 45 52
AZITHROMYCIN 93 45 47 36
PREDNISONE 90 57 48 42
ALENDRONATE SODIUM 89 79 49 57
DILTIAZEM 24HR CD 87 69 50 136
BUPROPION XL 86 65 51 207
CARISOPRODOL 82 12 R 52 72
PROMETHAZINE HCL 81 33 R 53 54
LYRICA 81 38 53 47
ETODOLAC 78 51 55 152
METOCLOPRAMIDE HCL 76 47 56 99
ACETAMINOPHEN-CODEINE 74 43 S3 57 127
DONEPEZIL HCL 74 74 57 32
METHYLDOPA 74 61 R 57 329
CRESTOR 74 42 57 30
PLAVIX 73 60 61 49
MECLIZINE HCL 71 63 62 80
LANTUS 68 50 63 68
DIOVAN 66 44 64 67
PROPRANOLOL HCL 66 62 64 135
MUPIROCIN 65 31 66 140
PANTOPRAZOLE SODIUM 64 61 67 28
VENTOLIN HFA 63 30 68 83
TAMSULOSIN HCL 63 49 68 33
LOSARTAN-HYDROCHLOROTHIAZIDE 63 60 68 38
DICLOFENAC SODIUM 61 24 71 123
DOXEPIN HCL 61 14 71 176
CYMBALTA 59 22 73 53
PAROXETINE HCL 59 43 73 63
SPIRONOLACTONE 59 33 73 78
GLYBURIDE 57 57 R 76 92
THEOPHYLLINE ANHYDROUS 53 40 77 186
INSULIN SYRINGE 52 32 78 93
BENAZEPRIL HCL 52 38 78 61
AMLODIPINE BESYLATE-BENAZEPRIL 51 51 80 59
RAMIPRIL 50 49 81 77
MIRTAZAPINE 50 43 81 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.